Skip to content
#protein folding Review Open access

Codon optimization as a design variable in biotherapeutics.

Oct 2026 · Trends in Biotechnology · 0 citations
Medicine

TL;DR

This opinion article presents the viewpoint on mechanisms, applications, and regulatory considerations for CO in biologics.

Abstract

Codon optimization (CO) is a key design variable in biotherapeutics that is used to enhance expression of recombinant proteins, gene therapies, and vaccines. Although synonymous codon substitutions were historically considered neutral, codon choice can influence messenger RNA (mRNA) stability, translation kinetics, cotranslational folding, and immunogenicity. Current optimization strategies integrate computational parameters including codon adaptation indices, tRNA availability, mRNA structure, cytosine-phosphate-guanine dinucleotide content, codon pair bias, and machine learning approaches to balance expression and product quality. Additionally, dynamic tRNA modifications within the epitranscriptome modulate codon-biased translation in a context-dependent manner. While CO has not been implicated in adverse clinical outcomes, its context-dependent effects on protein conformation, post-translational modifications, and immune responses necessitate rigorous characterization. This opinion article presents our viewpoint on mechanisms, applications, and regulatory considerations for CO in biologics.

Read PDF

Similar papers

Open access Dec 2025

Structural basis for start codon selection by eIF5-mimic proteins

Start codon selection extensively regulates the cellular proteome and is implicated in cancer and other diseases. The eIF5-mimic proteins (5MPs: 5MP1/BZW2 and 5MP2/BZW1) restrict non-AUG start codon usage and thereby reprogram proteoform expression from mRNAs with alternative start sites, such as the oncogenic c-Myc. H...

Ximena Zottig, Chun-Ying Huang, Z. Seraj et al. · 2 citations
Open access Sep 2026

Sequence optimization targeting mRNA stability enhances monoclonal antibody titers in CHO cells.

This study presents a DNA sequence optimization approach that integrates mRNA stability as a tunable design parameter to enhance monoclonal antibody expression in Chinese hamster ovary (CHO) cells. A comprehensive combinatorial library of synonymous coding-sequence variants of an IgG1 light chain was integrated as sing...

S. Schneckener, Kathrina Haag, Samuel Leweke et al. · 0 citations
Review Open access Sep 2026

Aminoacyl-tRNA synthetases in tumor immunity: canonical translation, source-resolved immune circuits and therapeutic opportunities

Aminoacyl-tRNA synthetases (aaRSs) generate the aminoacyl-tRNA pool required for protein synthesis, yet selected family members also participate in nutrient sensing, stress adaptation, metabolite-dependent protein modification and extracellular immune communication. This dual biology creates a recurrent interpretive pr...

Zhi-Peng Zhao, Ru-Dong Li, Si-Yi Wang et al. · 0 citations
Open access Sep 2026

Recoding by N1-methylpseudouridine guides rational mRNA vaccine design

N1-methylpseudouridine (m1Ψ) is a key modification used in SARS-CoV-2 mRNA vaccines that reduces immunogenicity and increases mRNA stability. Recent studies suggested that m1Ψ can promote ribosomal frameshifting, a translational error generating aberrant peptides that elicit immune responses, raising concerns about uni...

Panagiotis Poulis, Giovanni Robecchi, Arina O. Kurochkina et al. · 0 citations
Review Open access Oct 2026

AI-integrated RNA therapeutics in precision oncology

Summary RNA therapeutics can silence oncogenic transcripts, modulate RNA processing, restore protein expression, or encode tumor antigens. Their development, however, is constrained by target selection, molecular design, delivery, immunogenicity, and inter-patient heterogeneity. Artificial intelligence (AI) is increasi...

William S. O. Symmans, Zi-Yi Li, G. Calin et al. · 0 citations
Open access Oct 2026

Regulatable In Vivo Gene Expression via Adaptamers

SUMMARY Precise, reversible control of transgene expression is essential for safe and durable gene therapy, yet current inducible systems remain difficult to translate in vivo due to large size, limited induction duration, and dependence on immunogenic regulators. Here we present the adaptamer (ADAR modulatable aptamer...

Jack Bryant, L. Herron, Yesh Doctor et al. · 0 citations

Related blog posts

Google DeepMind Blog Sep 30, 2026

Introducing SynthID Bio

Proof of concept for watermarking AI-generated proteins while preserving biological function.

MIT News · Artificial Intelligence Aug 27, 2026

Looking beyond natural sequences

A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.